Misplaced Pages

Furafylline: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 11:57, 11 July 2011 editEdgar181 (talk | contribs)Extended confirmed users196,325 edits +Category:Xanthines; +Category:Furans using HotCat← Previous edit Latest revision as of 12:33, 30 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers170,249 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
(21 intermediate revisions by 16 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| Verifiedfields = changed
| name = Furafylline
| Watchedfields = changed
| IUPAC_name = 3-(furan-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione
| verifiedrevid = 438896400
| image = Furafylline.svg
| IUPAC_name = 3-(Furan-2-ylmethyl)-1,8-dimethyl-7''H''-purine-2,6-dione
| alt =
| image = Furafylline structure.svg
| caption =
| tradename = | width = 150
| Drugs.com = | alt =
| MedlinePlus = | caption =

| CAS_number = 80288-49-9
<!--Clinical data-->
| ATCvet =
| tradename =
| ATC_prefix = <!-- 'none' if uncategorised -->
| ATC_suffix = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| PubChem = 3433 | pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| DrugBank =
| chemical_formula = C<sub>12</sub>H<sub>12</sub>N<sub>4</sub>O<sub>3</sub>
| molecular_weight = 60.25 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = | legal_status =
| routes_of_administration = | routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 80288-49-9
| ATCvet =
| ATC_prefix = None
| ATC_suffix =
| PubChem = 3433
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = C2087G0XX3
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 372638
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3315

<!--Chemical data-->
| C=12 | H=12 | N=4 | O=3
| smiles = Cc1c2c(n1)n(c(=O)n(c2=O)C)Cc3ccco3
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C12H12N4O3/c1-7-13-9-10(14-7)16(6-8-4-3-5-19-8)12(18)15(2)11(9)17/h3-5H,6H2,1-2H3,(H,13,14)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = KGQZGCIVHYLPBH-UHFFFAOYSA-N
}} }}

'''Furafylline''' is a ] derivative that was introduced in hope of being a long-acting replacement for ] in the treatment of ].<ref name=Sesardic1990>{{cite pmid| 2378786}}</ref> It is an inhibitor of ].<ref name=Sesardic1990/> '''Furafylline''' is a ] derivative that was introduced in hope of being a long-acting replacement for ] in the treatment of ].<ref name=Sesardic1990>{{cite journal | vauthors = Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS | title = Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man | journal = British Journal of Clinical Pharmacology | volume = 29 | issue = 6 | pages = 651–63 | date = June 1990 | pmid = 2378786 | pmc = 1380167 | doi = 10.1111/j.1365-2125.1990.tb03686.x }}</ref> It is an inhibitor of ].<ref name=Sesardic1990/>


==References== ==References==
{{reflist}} {{Reflist}}


{{Asthma and copd rx}}
{{drug-stub}}
{{Phosphodiesterase inhibitors}}

]
]
]
] ]

]
{{respiratory-system-drug-stub}}